11 – 20 of 85
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2019
-
Mark
Oscillometry in Chronic Obstructive Lung Disease : In vitro and in vivo evaluation of the impulse oscillometry and tremoflo devices
- Contribution to journal › Article
-
Mark
Survival in the Swedish cohort with alpha-1-antitrypsin deficiency, up to the age of 43-45 years
- Contribution to journal › Article
-
Mark
Liver disease in adults with severe alpha-1-antitrypsin deficiency
- Contribution to journal › Article
-
Mark
Decline in FEV1 and hospitalized exacerbations in individuals with severe alpha-1 antitrypsin deficiency
- Contribution to journal › Article
- 2018
-
Mark
Deposition of inhaled nanoparticles is reduced in subjects with COPD and correlates with the extent of emphysema : Proof of concept for a novel diagnostic technique
- Contribution to journal › Article
-
Mark
Lung function and CT lung densitometry in 37-to 39-year-old individuals with alpha-1-antitrypsin deficiency
- Contribution to journal › Article
- 2017
-
Mark
Health status and lung function in the Swedish alpha 1-antitrypsin deficient cohort, identified by neonatal screening, at the age of 37-40 years
- Contribution to journal › Article
-
Mark
Long-term efficacy and safety of α1 proteinase inhibitor treatment for emphysema caused by severe α1 antitrypsin deficiency : an open-label extension trial (RAPID-OLE)
- Contribution to journal › Article
-
Mark
Survival in individuals with severe alpha 1-antitrypsin deficiency (PiZZ) in comparison to a general population with known smoking habits
- Contribution to journal › Article
-
Mark
European Respiratory Society statement : Diagnosis and treatment of pulmonary disease in α1-antitrypsin deficiency
- Contribution to journal › Article
